TY - JOUR
T1 - Metabolomics-based mass spectrometry methods to analyze the chemical content of 3D organoid models
AU - Murphy, Shannon E.
AU - Sweedler, Jonathan V.
N1 - The authors acknowledge support by Award Number P30 DA018310 from the National Institute on Drug Abuse (J. V. S.), and the National Science Foundation under grant 1735252 (S. E. M.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies.
PY - 2022/5/30
Y1 - 2022/5/30
N2 - Metabolomics, the study of metabolites present in biological samples, can provide a global view of sample state as well as insights into biological changes caused by disease or environmental interactions. Mass spectrometry (MS) is commonly used for metabolomics analysis given its high-throughput capabilities, high sensitivity, and capacity to identify multiple compounds in complex samples simultaneously. MS can be coupled to separation methods that can handle small volumes, making it well suited for analyzing the metabolome of organoids, miniaturized three-dimensional aggregates of stem cells that model in vivo organs. Organoids are being used in research efforts to study human disease and development, and in the design of personalized drug treatments. For organoid models to be useful, they need to recapitulate morphological and chemical aspects, such as the metabolome, of the parent tissue. This review highlights the separation- and imaging-based MS-based metabolomics methods that have been used to analyze the chemical contents of organoids. Future perspectives on how MS techniques can be optimized to determine the accuracy of organoid models and expand the field of organoid research are also discussed.
AB - Metabolomics, the study of metabolites present in biological samples, can provide a global view of sample state as well as insights into biological changes caused by disease or environmental interactions. Mass spectrometry (MS) is commonly used for metabolomics analysis given its high-throughput capabilities, high sensitivity, and capacity to identify multiple compounds in complex samples simultaneously. MS can be coupled to separation methods that can handle small volumes, making it well suited for analyzing the metabolome of organoids, miniaturized three-dimensional aggregates of stem cells that model in vivo organs. Organoids are being used in research efforts to study human disease and development, and in the design of personalized drug treatments. For organoid models to be useful, they need to recapitulate morphological and chemical aspects, such as the metabolome, of the parent tissue. This review highlights the separation- and imaging-based MS-based metabolomics methods that have been used to analyze the chemical contents of organoids. Future perspectives on how MS techniques can be optimized to determine the accuracy of organoid models and expand the field of organoid research are also discussed.
UR - http://www.scopus.com/inward/record.url?scp=85131862612&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85131862612&partnerID=8YFLogxK
U2 - 10.1039/d2an00599a
DO - 10.1039/d2an00599a
M3 - Review article
C2 - 35660810
AN - SCOPUS:85131862612
SN - 0003-2654
VL - 147
SP - 2918
EP - 2929
JO - Analyst
JF - Analyst
IS - 13
ER -